BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 830274)

  • 1. Depressor effect of saralasin in hypertensive crisis due to pheochromocytoma.
    Röckel A; Heidland A; Appel E; Palm D
    N Engl J Med; 1977 Jan; 296(1):50-1. PubMed ID: 830274
    [No Abstract]   [Full Text] [Related]  

  • 2. Pheochromocytoma crisis induced by saralasin. Relation of angiotensin analogue to catecholamine release.
    Dunn FG; De Carvalho JG; Kem DC; Higgins JR; Frohlich ED
    N Engl J Med; 1976 Sep; 295(11):605-7. PubMed ID: 820996
    [No Abstract]   [Full Text] [Related]  

  • 3. [Saralasin in resistant hypertensive crisis (author's transl)].
    Röckel A; Heidland A
    Med Klin; 1979 Mar; 74(11):401-7. PubMed ID: 34782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of saralasin on hypertension due to phaeochromocytoma.
    Donker AJ
    Lancet; 1984 Aug; 2(8398):355. PubMed ID: 6146900
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial correction of hypertension by angiotensin II blockade in a patient with phaeochromocytoma.
    van Hoogdalem P; Donker AJ; Brentjens JR; van der Hem GK; Oosterhuis JW
    Acta Med Scand; 1977; 201(4):395-9. PubMed ID: 15405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG; Parker FB; Poirier RA; Anderson G; Streeten DH; Blackman M
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ; Baer L; Radichevich I
    Cardiovasc Clin; 1978; 9(1):183-95. PubMed ID: 667880
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
    Bönner G; Lang R; Hummerich W; Helber A; Meurer KA; Wambach G; Kaufmann W
    Med Welt; 1980 Sep; 31(38):1362, 1363-5. PubMed ID: 7001167
    [No Abstract]   [Full Text] [Related]  

  • 9. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency].
    Tuma J; Beckerhoff R; Záruba K; Furrer J; Vetter W
    Schweiz Med Wochenschr; 1977 May; 107(20):704-9. PubMed ID: 867013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-hypertensive effect of the angiotensin II antagonist saralasin acetate, a diagnostic criterion of renovascular hypertension].
    Wessels F; Wagner H; Erhard R; Peters P; Losse H
    Med Welt; 1978 Mar; 29(9):339-41. PubMed ID: 634129
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Hypotension during angiotensin blockade with saralasin.
    Pettinger WA; Keeton K
    Lancet; 1975 Jun; 1(7921):1387-8. PubMed ID: 48980
    [No Abstract]   [Full Text] [Related]  

  • 17. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood pressure behavior following 1-sar-8-ala-angiotensin II (saralasin) in essential and renovascular hypertension].
    Rosenthal J; Franz HE
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1305-7. PubMed ID: 1029984
    [No Abstract]   [Full Text] [Related]  

  • 19. Lowering of hypertension by central saralasin in the absence of plasma renin.
    Phillips MI; Mann JF; Haebara H; Hoffman WE; Dietz R; Schelling P; Ganten D
    Nature; 1977 Dec; 270(5636):445-7. PubMed ID: 593364
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.